Associations of rs1883832 and rs4810485 polymorphisms of CD40 gene with myocardial infarction in the Tunisian population

References

• Armitage, R.J., et al., 1992. Molecular and biological characterization of a murine ligand for CD40. Nature, 357 (6373), 80–82.
   PubMed Web of Science ®Google Scholar
• Chen, J.-M., et al., 2015. The association of CD40 polymorphisms with CD40 serum levels and risk of systemic lupus erythematosus. BMC genetics, 16, 121.
   PubMed Web of Science ®Google Scholar
• Friedewald, W.T., Levy, R.I., and Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 18 (6), 499–502.
   PubMed Web of Science ®Google Scholar
• Huang, H.T., et al., 2017. A SNP in 5’ untranslated region of CD40 gene is associated with an increased risk of ischemic stroke in a Chinese population: a case-control study. Genetics and molecular biology, 40 (2), 442–449.
   PubMed Web of Science ®Google Scholar
• Kuo, H.C., et al., 2012. CD40 gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population. The scientific world journal, 2012, 1–5.
   Google Scholar
• Lee, Y.H., et al., 2015. Associations between the functional CD40 rs4810485 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Lupus, 24 (11), 1177–1183.
   PubMed Web of Science ®Google Scholar
• Li, J., et al., 2015. Soluble CD40L is a useful marker to predict future strokes in patients with minor stroke and transient ischemic attack. Stroke, 46 (7), 1990–1992.
   PubMed Web of Science ®Google Scholar
• Luhiri, D.K., and Nunberger, J.I., 1991. A rapid non-enzymatic method for the preparation of HMW from blood for RFLP studies. Nucleic acids research, 19, 5444.
   PubMed Web of Science ®Google Scholar
• Lusis, A.J., 2000. Atherosclerosis. Nature, 407 (6801), 233–241.
   PubMed Web of Science ®Google Scholar
• Ma, Y., et al., 2013. Single nucleotide polymorphism of CD40 in the 5'-untranslated region is associated with ischemic stroke. Gene, 529 (2), 257–261.
   PubMed Web of Science ®Google Scholar
• Mach, F., et al., 1998. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature, 394 (6689), 200–203.
   PubMed Web of Science ®Google Scholar
• Marjo, M., et al., 2008. The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling, Blood, 111, 4596–4604.
   Google Scholar
• Mercedes, G., et al., 2012. Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients. PLoS One, 7, 1–9.
   Google Scholar
• Morio, T., Hanissian, S., and Geha, R.S., 1995. Characterization of a 23-kDa protein associated with CD40. Proceedings of the national academy of sciences of the United States of america, 92 (25), 11633–11636.
   PubMed Web of Science ®Google Scholar
• Noelle, R.J., Ledbetter, J.A., and Aruffo, A., 1992. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunology today 1992, 13 (11), 431–433.
   Google Scholar
• Nordlie, M.A., Wold, L.E., and Kloner, R.A., 2005. Genetic contributors toward increased risk for ischemic heart disease. Journal of molecular and cellular cardiology, 39 (4), 667–679.
   PubMed Web of Science ®Google Scholar
• Park, C.I., et al., 2005. Characterization and expression of a CD40 homolog gene in Japanese flounder Paralichthys olivaceus. Immunogenetics, 57 (9), 682–689.
   PubMed Web of Science ®Google Scholar
• Ross, R., 1999. Atherosclerosis-an inflammatory disease. The new England journal of medicine, 340 (2), 115–126.
   PubMed Web of Science ®Google Scholar
• Schönbeck, U., and Libby, P., 2001. The CD40/CD154 receptor/ligand dyad. Cellular and molecular life sciences, 58 (1), 4–43.
   PubMed Web of Science ®Google Scholar
• Schonbeck, U., and Libby, P., 2001. CD40 signaling and plaque instability. Circulation research, 89 (12), 1092–1103.
   PubMed Web of Science ®Google Scholar
• Shah, S.H., 2007. Gene polymorphisms and susceptibility to coronary artery disease. Pediatric blood & cancer, 48, 738–741.
   PubMed Web of Science ®Google Scholar
• Tian, W., Ren, G., and Bikui, Z., 2012. Developments in the study of CD40/CD40L gene and its polymorphism in atherosclerosis. Journal of Central South university, 37, 413–418.
   Google Scholar
• Vazgiourakis, V.M., et al., 2011. A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis. Annals of the rheumatic diseases, 70 (12), 2184–2190.
   PubMed Web of Science ®Google Scholar
• Wang, M., et al., 2011. The CD40 gene polymorphism rs1883832 is associated with risk of acute coronary syndrome in a Chinese case-control study. DNA and cell biology, 30 (3), 173–178.
   PubMed Web of Science ®Google Scholar
• Yan, J., et al., 2010. Association analysis of CD40 gene polymorphism with acute coronary syndrome. Clinical and experimental medicine, 10 (4), 253–258.
   PubMed Web of Science ®Google Scholar
• Yan, J.C., et al., 2004. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes. Clinica chimica acta; international journal of clinical chemistry, 343 (1–2), 155–159.
   PubMed Web of Science ®Google Scholar
• Yan, Y., Chi, M., and Xiao Chun, M., 2014. The SNP rs1883832 in CD40 gene and risk of atherosclerosis in Chinese population: a meta-analysis. Plos one, 9, 1–12.
   Web of Science ®Google Scholar
• Zhang, B., et al., 2013. Association of CD40-1C/T polymorphism with cerebral infarction susceptibility and its effect on sCD40L in Chinese population. International immunopharmacology, 16 (4), 461–465.
   PubMed Web of Science ®Google Scholar